Towards a cure for all: How we might do it
Zinc finger gene therapy produces HIV-resistant CD4 T-cells
Statin therapy reduces immune activation in HIV-positive patients
Towards a cure for all (part one)
Bristol-Myers Squibb buys festinavir, new NRTI active against MDR HIV
Stem cell transplant has cured HIV infection in 'Berlin patient', say doctors
